(Q39691125)

14 September 2017

Overcoming radiation resistance in inflammatory breast cancer (English)

1 reference

14 September 2017

0 references

Wendy A Woodward

1

0 references

author name string

Bisrat G Debeb

series ordinal

2

1 reference

14 September 2017

Wei Xu

series ordinal

3

1 reference

14 September 2017

Thomas A Buchholz

series ordinal

4

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 June 2010

1 reference

14 September 2017

1 reference

14 September 2017

116

1 reference

14 September 2017

2840-2845

1 reference

14 September 2017

11 Suppl

1 reference

Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual

14 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25173

7 January 2021

Population-based statistics for women diagnosed with inflammatory breast cancer (United States).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25173

7 January 2021

Clinical experience with irradiation of inflammatory carcinoma of the breast with and without elective chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25173

7 January 2021

Effectiveness of mastectomy by response to induction chemotherapy for control in inflammatory breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25173

7 January 2021

Evolving treatment strategies for inflammatory breast cancer: a population-based survival analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25173

7 January 2021

Management of locally advanced carcinoma of the breast. II. Inflammatory carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25173

7 January 2021

Multimodal treatment for inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25173

7 January 2021

Locoregional treatment outcomes after multimodality management of inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25173

7 January 2021

Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25173

7 January 2021

The role of locoregional therapy in inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25173

7 January 2021

The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25173

7 January 2021

WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25173

7 January 2021

The lymphovascular embolus of inflammatory breast cancer expresses a stem cell-like phenotype

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25173

7 January 2021

In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25173

7 January 2021

Radiosensitivity of cancer-initiating cells and normal stem cells (or what the Heisenberg uncertainly principle has to do with biology)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25173

7 January 2021

Identification of tumor-initiating cells in a p53-null mouse model of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25173

7 January 2021

Prospective identification of tumorigenic breast cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25173

7 January 2021

A phase II study of second-line neoadjuvant chemotherapy with capecitabine and radiation therapy for anthracycline-resistant locally advanced breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25173

7 January 2021

Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer: mature results of a phase II trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25173

7 January 2021

Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25173

7 January 2021

Identifiers

DOI

10.1002/CNCR.25173

1 reference

14 September 2017

1 reference